Vaxart VXRT Income Statement (2010-2026)

OTC VXRT
$0.48 -0.01 (-1.94%)
As of: Oct 21, 2026 · 12:16 PM EDT
Reported Financials

Vaxart Quarterly Income Statement

Periods 65 quarters
Latest Jun 2026

Vaxart reported revenue of $27.18M and net income of -$13.49M for the quarter ended Jun 2026, down 31.6% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
0.20M0.07M0.09M0.02M0.68M1.36M2.10M3.25M2.18M6.40M4.93M15.19M20.88M39.73M72.41M104.24M39.23M27.19M
Cost of RevenueCost of Rev
Gross Profit
Operating items
Research & DevelopmentR&D
12.41M15.53M18.20M19.93M22.47M20.46M19.62M18.81M15.00M14.71M19.01M17.48M15.07M22.65M30.74M49.74M75.95M45.15M29.41M33.75M
Selling, General & AdministrativeSG&A
5.04M5.75M6.66M9.32M6.96M6.45M6.63M5.60M4.92M5.44M7.24M5.18M4.34M4.02M5.07M4.60M4.28M3.67M4.64M6.60M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
3.01M4.25M
Operating ExpensesOpex
17.45M24.29M24.86M29.25M29.43M31.16M26.25M24.41M19.92M20.15M26.25M22.66M19.41M26.68M35.81M54.33M80.22M48.82M34.05M40.36M
Operating IncomeOp. Inc
-17.25M-24.22M-24.78M-29.25M-29.43M-31.14M-25.57M-23.05M-17.82M-16.90M-24.07M-16.26M-14.48M-11.49M-14.94M-14.60M-7.81M55.42M5.17M-13.17M
EBIT
-17.25M-24.22M-24.78M-29.25M-29.43M-31.14M-25.57M-23.05M-17.82M-16.90M-24.07M-16.26M-14.48M-11.49M-14.94M-14.60M-7.81M55.42M5.17M-13.17M
Non-operating items
Non Operating Interest Expenses
Non Operating Investment IncomeNon-Op. Investment Inc.
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
0.00M-0.01M0.00M0.00M-0.06M0.00M0.00M0.01M0.02M0.01M0.00M0.00M-0.01M-0.04M-0.01M-0.33M
Non Operating IncomeNon Op. Inc.
Net income details
EBT
-17.56M-20.75M-25.08M-29.42M-29.29M-23.90M-25.11M-22.53M-17.36M-17.20M-24.37M-16.45M-14.06M-11.81M-15.50M-14.97M-8.12M55.39M5.21M-13.47M
Tax ProvisionsTaxes
0.02M0.02M0.02M0.02M0.02M0.02M0.03M0.02M0.04M0.17M0.05M0.02M0.02M0.18M0.10M0.02M0.02M0.34M0.03M0.03M
Profit After TaxPAT
-17.58M-20.76M-25.10M-29.43M-29.31M-23.92M-25.14M-22.55M-17.40M-17.38M-24.42M-16.47M-14.08M-11.99M-15.59M-14.99M-8.14M55.05M5.18M-13.49M
Income from Continuing OperationsIncome (Continuing)
-17.58M-20.76M-25.10M-29.43M-29.31M-23.92M-25.14M-22.55M-17.40M-17.38M-24.42M-16.47M-14.08M-11.99M-15.59M-14.99M-8.14M55.05M5.18M-13.49M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
-17.58M-20.76M-25.10M-29.43M-29.31M-23.92M-25.14M-22.55M-17.40M-17.38M-24.42M-16.47M-14.08M-11.99M-15.59M-14.99M-8.14M55.05M5.18M-13.49M
Income towards Parent CompanyParent Net Inc
-17.58M-20.76M-25.10M-29.43M-29.31M-23.92M-25.14M-22.55M-17.40M-17.38M-24.42M-16.47M-14.08M-11.99M-15.59M-14.99M-8.14M55.05M5.18M-13.49M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-17.58M-20.76M-25.10M-29.43M-29.31M-23.92M-25.14M-22.55M-17.40M-17.38M-24.42M-16.47M-14.08M-11.99M-15.59M-14.99M-8.14M55.05M5.18M-13.49M
Additional items
EPS (Basic)
-0.14-0.17-0.20-0.23-0.23-0.19-0.19-0.16-0.11-0.12-0.14-0.09-0.06-0.06-0.07-0.07-0.040.240.02-0.06
EPS (Diluted)
-2.41-2.84-3.44-4.03-4.01-3.28-3.44-3.09-2.38-2.38-3.34-2.26-1.93-0.06-0.07-0.07-0.040.240.02-0.06
Shares Outstanding
123.98M121.45M125.80M126.43M126.89M127.68M135.21M139.59M152.03M144.82M168.81M184.70M227.45M202.14M227.92M228.37M228.93M230.27M240.65M242.17M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
7.30M7.30M7.30M7.30M7.30M7.30M7.30M7.30M7.30M7.30M7.30M7.30M7.30M202.14M227.92M227.92M227.92M230.35M242.18M242.18M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
125.50M125.59M126.45M126.51M131.25M134.20M135.60M151.98M152.04M153.45M176.84M184.70M227.48M227.77M228.22M228.92M240.07M240.49M241.97M242.84M
EBITDA
-16.23M-23.02M-23.65M-28.03M-27.86M-29.25M-23.51M-20.89M-15.76M-14.57M-21.89M-14.04M-12.25M-9.26M-12.69M-12.41M-5.73M57.48M6.30M-12.43M
Interest ExpensesInt Expense
Tax Rate
0.62%0.56%

Vaxart Income Statement API

Pull Vaxart's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VXRT&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY